StockData
Elanco Animal Health Inc logo

Elanco Animal Health Inc (ELAN) stock

ELANNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30129% above fair value
$25.85−0.56 (-2.12%)

Close on Nov 17, 2026Market cap $12.92BP/E –Yield –

Elanco Animal Health total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Elanco Animal Health's total debt was $3.92B at Jun 30, 2026. For fiscal 2025 it was $4.02B, down 7.0% from the year before. The highest annual figure on record is $6.32B in fiscal 2021.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.02B-7.0%
FY2024Dec 31, 2024$4.32B-25.2%
FY2023Dec 31, 2023$5.77B-1.1%
FY2022Dec 31, 2022$5.84B-7.6%
FY2021Dec 31, 2021$6.32B+3.1%
FY2020Dec 31, 2020$6.13B+160.2%
FY2019Dec 31, 2019$2.36B-4.7%
FY2018Dec 31, 2018$2.47B–
FY2017Dec 31, 2017$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.92B-6.9%
Q1 FY2026Mar 31, 2026$3.99B-9.2%
Q4 FY2025Dec 31, 2025$4.02B-7.0%
Q3 FY2025Sep 30, 2025$4.02B-7.6%
Q2 FY2025Jun 30, 2025$4.21B-25.8%
Q1 FY2025Mar 31, 2025$4.40B-23.8%
Q4 FY2024Dec 31, 2024$4.32B-25.2%
Q3 FY2024Sep 30, 2024$4.36B-26.3%
Q2 FY2024Jun 30, 2024$5.68B-6.4%
Q1 FY2024Mar 31, 2024$5.77B-4.2%
Q4 FY2023Dec 31, 2023$5.77B-1.1%
Q3 FY2023Sep 30, 2023$5.91B+0.1%
Q2 FY2023Jun 30, 2023$6.06B-0.0%
Q1 FY2023Mar 31, 2023$6.02B-1.9%
Q4 FY2022Dec 31, 2022$5.84B-7.6%
Q3 FY2022Sep 30, 2022$5.90B-6.8%
Q2 FY2022Jun 30, 2022$6.06B-0.6%
Q1 FY2022Mar 31, 2022$6.13B-0.4%
Q4 FY2021Dec 31, 2021$6.32B+3.1%
Q3 FY2021Sep 30, 2021$6.33B+3.2%
Q2 FY2021Jun 30, 2021$6.10B+196.5%
Q1 FY2021Mar 31, 2021$6.16B+198.8%
Q4 FY2020Dec 31, 2020$6.13B+160.2%
Q3 FY2020Sep 30, 2020$6.14B+160.2%
Q2 FY2020Jun 30, 2020$2.06B-14.6%
Q1 FY2020Mar 31, 2020$2.06B-16.4%
Q4 FY2019Dec 31, 2019$2.36B-4.7%
Q3 FY2019Sep 30, 2019$2.36B-4.8%
Q2 FY2019Jun 30, 2019$2.41B–
Q1 FY2019Mar 31, 2019$2.47B–
Q4 FY2018Dec 31, 2018$2.47B–
Q3 FY2018Sep 30, 2018$2.48B–
Q4 FY2017Dec 31, 2017$0–

More Elanco Animal Health figures

See a number that looks wrong?